Affibody and Astra Tech enter into license and research agreement

Affibody and Astra Tech today announce the initiation of a license and research agreement. The scope is development of devices for safe blood management. Affibody will develop Affibody® molecules targeting blood components for removal of harmful proteins from patients’ blood. Affibody will ..